Skip to main content
. 2021 Oct 19;12(1):8006–8019. doi: 10.1080/21655979.2021.1981795

Figure 2.

Figure 2.

CASC9 promoted cell proliferation, migration and invasion in OVCAR-3 and OVCAR-3/DDP cells. A, Cell inhibitory rate in OVCAR-3 and OVCAR-3/DDP cells was evaluated by CCK-8 assay. *P < 0.05. B, CASC9 mRNA level was detected after transfection with shRNA-CASC9 or OverExp-CASC9. ***P < 0.001 versus control; ###P < 0.001 versus vector. C, Cell proliferation were identified by CCK-8 assay after transfection with shRNA-CASC9 or OverExp-CASC9. D, Cell inhibitory rate was identified by CCK-8 assay after transfection with shRNA-CASC9 or OverExp-CASC9. E, Cell migration was evaluated by wound healing assay after transfection with shRNA-CASC9 or OverExp-CASC9. F, Cell invasion was examined by transwell assay after transfection with shRNA-CASC9 or OverExp-CASC9. Data are expressed as mean ± SD. *P < 0.05, ***P < 0.001 versus OVCAR-3 cells; #P < 0.05, ##P < 0.01, ###P < 0.001 versus OVCAR-3/DDP+vector